| Title |
Author |
Type |
Date |
Words |
| Actinium Pharmaceuticals, Inc. Receives Notice of Patent Allowance for a Key Application. |
|
|
May 13, 2013 |
530 |
| Shire Wins Patent Trial Against Watson Concerning LIALDA. |
|
|
May 9, 2013 |
952 |
| Shire Wins Patent Trial Against Watson Concerning LIALDA. |
|
|
May 9, 2013 |
957 |
| Daniel Chung, Former Chief Trademark Counsel at Johnson & Johnson, Joins Cantor Colburn LLP. |
|
|
May 2, 2013 |
640 |
| Catabasis Pharmaceuticals Announces Issuance of Patents for CAT-1000 and CAT-2000 Series. |
|
|
Apr 30, 2013 |
1075 |
| Absorption Pharmaceuticals to Receive Patent for Premature Ejaculation Topical Medication. |
|
|
Apr 29, 2013 |
659 |
| Actavis Announces OxyContin Patent Challenge Settlement. |
|
|
Apr 26, 2013 |
1077 |
| China Chinese Patent Medicine Industry Report, 2012-2015. |
|
Industry overview |
Apr 22, 2013 |
2762 |
| Adamas Pharmaceuticals Announces Issuance of First US Patent for Nurelin(TM) (Amantadine HCl Extended Release) Program. |
|
|
Apr 22, 2013 |
804 |
| EPO appeal board decides in favor of the Wengel LNA patent. |
|
|
Apr 18, 2013 |
601 |
| EPO appeal board decides in favor of the Wengel LNA patent. |
|
|
Apr 18, 2013 |
608 |
| India's decision on blockbuster cancer drug makes good sense. |
|
|
Apr 17, 2013 |
995 |
| PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis to 2022. |
|
Industry overview |
Apr 10, 2013 |
1633 |
| ProfNet Experts Available on Pharmaceutical Patents, FBI Email Access, Energy Investments. |
|
|
Apr 10, 2013 |
2104 |
| The Zacks Analyst Blog Highlights: Novartis, AstraZeneca, Roche Holding, Pfizer and Gilead Sciences. |
|
|
Apr 8, 2013 |
1508 |
| Don't confuse means with ends. |
|
|
Apr 5, 2013 |
336 |
| USPTO issues Inter Partes Reexamination Certificate of key LNA patent. |
|
|
Apr 5, 2013 |
727 |
| USPTO issues Inter Partes Reexamination Certificate of key LNA patent. |
|
|
Apr 5, 2013 |
734 |
| Big Pharma down, not out, after Indian patent blow. |
|
|
Apr 4, 2013 |
1011 |
| Synthetic Biologics Announces Issuance of U.S. Patent Covering Combination of Estriol and Copaxone for Multiple Sclerosis. |
|
|
Apr 4, 2013 |
968 |
| MAIL TODAY COMMENT. |
|
|
Apr 3, 2013 |
729 |
| Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins. |
|
|
Apr 3, 2013 |
793 |
| Patent Trials In India: Why Multinational Drug Companies Need To Adopt Tailor-Made Business Model For Emerging Economies. |
|
|
Apr 3, 2013 |
820 |
| Patients pip patent. |
|
|
Apr 2, 2013 |
680 |
| India drug patent case 'will help poor'. |
|
|
Apr 2, 2013 |
341 |
| Healthcare campaigners hail Novartis patent rejection by Indian court. |
|
|
Apr 2, 2013 |
294 |
| India's rejection of drug patent could reverberate, say experts. |
|
|
Apr 2, 2013 |
787 |
| Swiss pharmaceutical Novartis loses seven-year-old patent fight in India. |
|
|
Apr 1, 2013 |
329 |
| SC rejection of Novartis patent for cancer drug a win win situation for cheaper foreign drugs in India. |
|
|
Apr 1, 2013 |
231 |
| Actavis Confirms Generic AndroGel 1.62% Patent Challenge. |
|
|
Apr 1, 2013 |
997 |
| SC dismisses Novartis' plea to patent cancer drug. |
|
|
Apr 1, 2013 |
158 |
| 'Will continue to invest in India, but cautiously': Novartis after SC ruling. |
|
|
Apr 1, 2013 |
500 |
| Actavis Confirms Favorable Ruling In Generic Pulmicort RESPULES Patent Suit. |
|
|
Apr 1, 2013 |
989 |
| International. |
Bateman, Chris |
|
Apr 1, 2013 |
807 |
| Diabetes Landscape: Market, Technology and Intellectual Property. |
|
|
Mar 28, 2013 |
6077 |
| Neurodegenerative Diseases Market to 2018 - New product entries in both niche and broader Parkinson's disease treatment will boost market despite patent cliff. |
|
|
Mar 27, 2013 |
5512 |
| Nutra Pharma Patent and Trademarks Published in India. |
|
|
Mar 25, 2013 |
807 |
| Epizyme Granted First Patent Covering Personalized Therapeutic Drug Candidate E7438. |
|
|
Mar 22, 2013 |
326 |
| In Age of Patent Expiration, Planning Groups for New Pharma Products Growing in Importance. |
|
|
Mar 9, 2013 |
634 |
| Actavis Confirms Generic Exelon Patch Patent Challenge. |
|
|
Mar 8, 2013 |
1068 |
| Drug giant loses appeal to halt sale of cheaper pills. |
|
|
Mar 6, 2013 |
258 |
| German drug maker Bayer to challenge India's ruling allowing cheaper cancer drug copy. |
|
|
Mar 6, 2013 |
228 |
| Australia : Australia Federal Court holds CRESTOR patents invalid. |
|
|
Mar 6, 2013 |
225 |
| United States Patent & Trademark Office Grants Pfizer Reissue Patent For Celebrex[R] (celecoxib capsules). |
|
|
Mar 5, 2013 |
265 |
| Actavis Confirms Generic Fortesta Patent Challenge. |
|
|
Mar 1, 2013 |
860 |
| Patent court to help firms. |
|
|
Feb 21, 2013 |
104 |
| Amarin and Forest Laboratories Under Review: Drug Makers Face Growing Generic Competition. |
|
|
Feb 15, 2013 |
773 |
| Amarin and Forest Laboratories Under Review: Drug Makers Face Growing Generic Competition. |
|
|
Feb 15, 2013 |
778 |
| High Profile HealthCare Companies: Leading Pharma Company Secures New Patents. |
|
|
Feb 14, 2013 |
1787 |
| Leading Pharmaceutical Companies Mid-day Trading with Mixed Results and also New Patent News Announced for Crown Marketing. |
|
|
Feb 14, 2013 |
1105 |
| Actavis Reaches Settlement with Mallinckrodt Over Exalgo 32 mg Dosage Strength. |
|
|
Feb 14, 2013 |
877 |
| High Profile HealthCare Companies: Leading Pharma Company Secures New Patents. |
|
|
Feb 14, 2013 |
1792 |
| Leading Pharmaceutical Companies Mid-day Trading with Mixed Results and also New Patent News Announced for Crown Marketing. |
|
|
Feb 14, 2013 |
1112 |
| Breckenridge Announces Approval for Pioglitazone Hydrochloride tablets. |
|
|
Feb 13, 2013 |
410 |
| R-Tech Ueno: Lawsuit Claiming Infringement of AMITIZA[R] Capsules Patents. |
|
|
Feb 12, 2013 |
515 |
| Targeted Medical Pharma is Assigned Comprehensive Pharmaceutical Billing Patent. |
|
|
Feb 12, 2013 |
496 |
| Collegium Pharmaceutical Inc. Announces Notice of Allowance for U.S. Patent Covering Oxycodone DETERx, a Tamper-Resistant, Extended-Release Opioid Product. |
|
|
Feb 12, 2013 |
575 |
| Sucampo Files Patent Infringement Lawsuit Against Anchen Pharmaceuticals and Par Pharmaceuticals. |
|
|
Feb 8, 2013 |
622 |
| Mystic Pharmaceuticals Receives U.S. Patent for Intranasal Delivery Technology for Pharmaceuticals and Biologics. |
|
|
Feb 7, 2013 |
390 |
| Celsion Corporation Provides an Update Regarding ThermoDox Agreements with Zhejiang HISUN Pharmaceutical Company for China. |
|
|
Feb 5, 2013 |
971 |
| Pfizer Wins RAPAMUNE[R] Patent Case in Delaware District Court. |
|
|
Jan 31, 2013 |
1115 |
| Actavis Confirms District Court Ruling In Generic Rapamune Patent Suit. |
|
|
Jan 31, 2013 |
903 |
| Targeted Medical Pharma Receives Notice of Issuance for Comprehensive Billing Patent. |
|
|
Jan 30, 2013 |
511 |
| LILLY (ELI) & COMPANY - Lilly Reports Q4 and Full-Year 2012 Results. |
|
Financial report |
Jan 29, 2013 |
6868 |
| TetraLogic Pharmaceuticals Announces Decision to Grant Japanese Patent on Birinapant. |
|
Clinical report |
Jan 28, 2013 |
439 |
| Auxilium Pharmaceuticals, Inc. and Xstelos Holdings, Inc. File Lawsuit Against Upsher-Smith Laboratories, Inc. for Infringement of Testim Patents. |
|
|
Jan 28, 2013 |
1733 |
| Switzerland : Novartis delivers strong innovation in 2012, offsetting patent expirations; next growth phase expected to begin in 2013. |
|
|
Jan 24, 2013 |
474 |
| Fuisz Pharma Announces Patent Allowance For New Tablet And Caplet Shapes That Promote Rapid, Reliable Esophageal Transit. |
|
|
Jan 23, 2013 |
683 |
| Watson Confirms Opana ER Patent Challenge. |
|
|
Jan 23, 2013 |
767 |
| Spectrum Pharmaceuticals Announces Extension of FUSILEV[R] (levoleucovorin) for Injection Patent Until 2022. |
|
|
Jan 17, 2013 |
1091 |
| Technical Review: New Releases from Drug Maker Majors Cushion Against Patent Cliff Effects. |
|
|
Jan 16, 2013 |
612 |
| Technical Review: New Releases from Drug Maker Majors Cushion Against Patent Cliff Effects. |
|
|
Jan 16, 2013 |
617 |
| Which Biotech Companies Are Turning the Tables on Patent Cliffs? |
|
|
Jan 14, 2013 |
963 |
| Which Biotech Companies Are Turning the Tables on Patent Cliffs? |
|
|
Jan 14, 2013 |
968 |
| Therapies and Biomarkers for Inflammatory Bowel Disease. |
|
|
Jan 8, 2013 |
4498 |
| EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in Pharmaceuticals. |
|
|
Dec 28, 2012 |
988 |
| EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in Pharmaceuticals. |
|
|
Dec 28, 2012 |
993 |
| Watson Confirms Velcade Patent Challenge. |
|
|
Dec 28, 2012 |
856 |
| Atlantic Pharmaceuticals, Inc. Announces Two Patent Issuances for Its Tamper-Resistant Pharmaceutical Platform. |
|
|
Dec 20, 2012 |
565 |
| For the Treatment of Osteoporosis, Patent Expiries of Key Agents Will Trigger a Further Decline in Sales for the Bisphosphonates Drug Class Through 2021. |
|
|
Dec 6, 2012 |
590 |
| Jazz Pharmaceuticals Announces Issuance of Additional Xyrem Patent. |
|
|
Dec 4, 2012 |
365 |
| Jazz Pharmaceuticals Announces Issuance of Additional Xyrem Patent. |
|
|
Dec 4, 2012 |
371 |
| Through 2021, Major Constraints in the Hospital-Treated Infections Drug Market Will Include the Loss of Patent Protection for Key Branded Products--Notably Pfizer's Zyvox--and Continued Generic Erosion of Premium-Priced Agents Such as Meropenem. |
|
|
Dec 3, 2012 |
598 |
| Fighting intellectual property theft. |
Holbrook, Emily |
|
Dec 1, 2012 |
879 |
| Janssen Announces Intent Not to Enforce Patents for Darunavir in Resource-Limited Settings. |
|
|
Nov 29, 2012 |
970 |
| Janssen Announces Intent Not to Enforce Patents for Darunavir in Resource-Limited Settings. |
|
|
Nov 29, 2012 |
992 |
| Rexahn Pharmaceuticals Issued US Patent for Quinoxalinyl-piperazine Compounds. |
|
|
Nov 21, 2012 |
604 |
| TCI ClampConnect[TM] Sanitary Fitting from L.J. Star Receives Patent. |
|
|
Nov 20, 2012 |
435 |
| International Drug & Explosives Detection Company IDenta Corp. Receives Patent for New Sniffer. |
|
|
Nov 20, 2012 |
745 |
| HIV/AIDS Therapeutics Market to 2018 - Despite Major Patent Expiries, Increased Uptake of Once-a-Day Fixed-dose Combination Drugs to Drive Growth. |
|
|
Nov 19, 2012 |
2800 |
| Impax Laboratories and ThoRx Laboratories Confirm Patent Challenge Relating to Generic OPANA[R] ER 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 30 mg, and 40 mg. |
|
|
Nov 16, 2012 |
924 |
| Auspex Pharmaceuticals Receives U.S. Patent on Novel JAK Inhibitor SD-900. |
|
|
Nov 15, 2012 |
600 |
| Research and Markets: Global Genitourinary Drugs Market 2011-2015 Report Reveals That One of the Major Challenges is the Increase in the Patent Expiries of the Best-Selling Drugs in the Market. |
|
|
Nov 12, 2012 |
375 |
| Watson Announces Sale of Rugby OTC Product Trademark and Assets to Major Pharmaceuticals, a division of The Harvard Drug Group, LLC. |
|
|
Oct 29, 2012 |
1005 |
| LILLY (ELI) & COMPANY - 3rd Quarter Results. |
|
Financial report |
Oct 25, 2012 |
5518 |
| Fitch: Patent Cliff Causes Eli Lilly Revenue to Tumble. |
|
|
Oct 24, 2012 |
628 |
| Isis Pharmaceuticals To Receive $1.1 Million From Alnylam. |
|
|
Oct 23, 2012 |
726 |
| Bayer's Investigational Riociguat Meets Primary Endpoint in Phase III Study in Patients with Pulmonary Arterial Hypertension (PAH). |
|
|
Oct 22, 2012 |
1052 |
| Concert Pharmaceuticals Announces Issuance of U.S. Patent for its Lead Drug Candidate CTP-499. |
|
|
Oct 22, 2012 |
579 |
| TetraLogic Pharmaceuticals Granted Third U.S. Patent on Birinapant. |
|
Clinical report |
Oct 9, 2012 |
355 |
| Spectrum Pharmaceuticals Announces the USPTO Has Granted Five-Year Extension for FOLOTYN[R] Patent. |
|
|
Oct 8, 2012 |
1220 |
| MEI Pharma Issued European Patent For Lead Mitochondrial Inhibitor Drug Candidate ME-344. |
|
|
Oct 2, 2012 |
700 |
| Dow AgroSciences Awarded Costs of $5.3 Million Based on Bayer's Inequitable Conduct. |
|
|
Oct 1, 2012 |
268 |
| Generic Plavix competitors set to distribute. |
Richmond, M. |
Brief article |
Oct 1, 2012 |
146 |
| Bashing buy-offs: circuit split reignites the debate over reverse-payment settlements. |
Seidenberg, Steven |
|
Sep 29, 2012 |
1264 |
| Provectus Pharmaceuticals' Patent Application Published for Combining Local and Systemic Therapies for Enhanced Treatment of Cancer. |
|
|
Sep 28, 2012 |
461 |
| Bayer appeals one of its cases against Dow AgroSciences. |
|
|
Sep 28, 2012 |
414 |
| Horizon Pharma Announces Receipt of Two Additional U.S. Patent Allowances for DUEXIS. |
|
|
Sep 28, 2012 |
988 |
| Oral Arguments in the UCSF Appeal of United States Patent and Trademark Office Judgment in Favor of InSite Vision Are Scheduled for November 6, 2012. |
|
|
Sep 27, 2012 |
801 |
| Rexahn Pharmaceuticals Granted European Patent for Novel Anti-cancer Isoquinolinamine Compounds. |
|
|
Sep 26, 2012 |
600 |
| Research and Markets: Generics Analysis: Key Patent Case Reviews. |
|
|
Sep 25, 2012 |
285 |
| United States : For OXECTA, ACURA PHARMACEUTICALS INC. disclosed Paragraph IV ANDA Filing. |
|
|
Sep 22, 2012 |
118 |
| Generics Analysis: Key Patent Case Reviews. |
|
|
Sep 20, 2012 |
542 |
| New U.S. Composition of Matter Patent for Aradigm's Pulmaquin[TM] and Lipoquin[TM] Provides Protection Until 2031. |
|
|
Sep 18, 2012 |
797 |
| Research and Markets: The Global Peripheral Vascular Devices Market to Grow At A CAGR Of 6.5 Percent over the Period 2011-2015. |
|
|
Sep 14, 2012 |
342 |
| /C O R R E C T I O N -- Jazz Pharmaceuticals/. |
|
Correction notice |
Sep 12, 2012 |
386 |
| /C O R R E C T I O N -- Jazz Pharmaceuticals/. |
|
Correction notice |
Sep 11, 2012 |
393 |
| Jazz Pharmaceuticals Announces Issuance of New Formulation Patent for Xyrem. |
|
|
Sep 11, 2012 |
313 |
| India : PFIZER and MYLAN settles patent dispute. |
|
|
Sep 10, 2012 |
129 |
| United States : ISIS PHARMA to get $1.4 Mln from ALNYLAM. |
|
|
Sep 7, 2012 |
150 |
| Perrigo Confirms First To File Patent Challenge For Generic Version Of ProAir HFA Inhalation Aerosol. |
|
|
Sep 6, 2012 |
745 |
| Aradigm Patent Protection for Smoking Cessation is Extended with Issuance of a Method of Treatment Patent. |
|
|
Sep 5, 2012 |
622 |
| IPO initiates solid steps for setting up IP tribunals: Afridi. |
|
|
Sep 5, 2012 |
388 |
| Roche Selects Thomson Reuters to Transform the Management of Its Intellectual Property Assets. |
|
Company overview |
Sep 5, 2012 |
797 |
| Roche Selects Thomson Reuters to Transform the Management of Its Intellectual Property Assets. |
|
Company overview |
Sep 5, 2012 |
804 |
| Santarus Announces Appellate Court Reversal in Part of ZEGERID Invalidity Decision. |
|
|
Sep 4, 2012 |
923 |
| Research and Markets: Nintedanib - Comprehensive patent search. |
|
|
Aug 31, 2012 |
369 |
| AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms. |
|
|
Aug 29, 2012 |
1064 |
| VERONA PHARMA PLC - US Patent Granted for Verona Pharma's RPL554. |
|
|
Aug 28, 2012 |
525 |
| Isis Pharmaceuticals to receive $1.4 million from Alnylam. |
|
|
Aug 28, 2012 |
718 |
| Depomed Licenses Acuform Patents to Janssen Pharmaceuticals, Inc. |
|
|
Aug 27, 2012 |
558 |
| Novartis case: Patents versus patients. |
|
|
Aug 26, 2012 |
646 |
| U.S. Court of Appeals Upholds Validity of Lilly's Alimta Compound Patent. |
|
|
Aug 24, 2012 |
408 |
| LILLY (ELI) & COMPANY - Lilly's Alimta Patent Upheld by US Court of Appeals. |
|
|
Aug 24, 2012 |
421 |
| Lilly Wins Court Battle To Exclusively Sell Chemo Drug. |
|
|
Aug 24, 2012 |
307 |
| Indian campaigners say Novartis' win in landmark drug patent case would be 'death sentence' for poor and ill. |
|
|
Aug 22, 2012 |
350 |
| Research and Markets: The Patent Cliff: How Pfizer has responded to the loss of its best-selling drug. |
|
Company overview |
Aug 22, 2012 |
446 |
| Battle begins. |
|
|
Aug 21, 2012 |
528 |
| Transcept Pharmaceuticals Announces Listing of New U.S. Patent for Intermezzo in FDA's Orange Book. |
|
|
Aug 21, 2012 |
842 |
| New Patents Issued to Diffusion Pharmaceuticals. |
|
|
Aug 16, 2012 |
437 |
| New Patent Issued for Mannatech's Ambrotose[R] Technology. |
|
|
Aug 9, 2012 |
639 |
| Cushioning the Patent Impact and Preparing for Growth: Analysis of Big Pharma's Diversification Strategies to Overcome Industry Challenges. |
|
|
Aug 9, 2012 |
407 |
| Total Atorvastatin Use Increased Following Lipitor Patent Loss. |
|
|
Aug 7, 2012 |
583 |
| Avanir Pharmaceuticals Announces Listing Of Additional NUEDEXTA Patent In FDA Orange Book. |
|
|
Aug 3, 2012 |
1330 |
| AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms. |
|
|
Aug 1, 2012 |
1130 |
| UK reaps "patent dividend" as medicines bill falls. |
|
|
Aug 1, 2012 |
454 |
| Watson Confirms Epiduo Gel Patent Challenge. |
|
|
Jul 30, 2012 |
837 |
| BioAlliance Pharma announces the grant of US patent covering Sitavig[R]. |
|
|
Jul 26, 2012 |
707 |
| Fitch: Global Pharmaceutical Approvals Moderate as Patent Cliff Peaks. |
|
|
Jul 25, 2012 |
447 |
| LILLY (ELI) & COMPANY - Lilly Reports Q2 2012 Results, Raises 2012 EPS Guidance. |
|
Financial report |
Jul 25, 2012 |
4969 |
| United States : Derma Sciences Announces Issuance of Two New U.S. Patents For DSC127. |
|
|
Jul 24, 2012 |
442 |
| Derma Sciences Announces Issuance of Two New U.S. Patents For DSC127. |
|
|
Jul 23, 2012 |
788 |
| Research and Markets: MDV-3100 - Comprehensive patent search. |
|
|
Jul 17, 2012 |
324 |
| Research and Markets: Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth. |
|
|
Jul 12, 2012 |
366 |
| BioAlliance Pharma extends and strengthens the protection of AMEP[R] with the grant of two patents in the US. |
|
|
Jul 12, 2012 |
841 |
| SCOLR Pharma Announces Issuance of European Patent for CDT Ibuprofen. |
|
|
Jul 11, 2012 |
459 |
| A.P. Pharma Announces the Allowance of Three Patents Covering APF530. |
|
|
Jul 10, 2012 |
644 |
| CytRx Announces Allowance of U.S. Patent Application for Tamibarotene Capsule. |
|
|
Jul 9, 2012 |
880 |
| Research and Markets: The Chinese R&D Landscape - Pharmaceuticals. |
|
|
Jul 4, 2012 |
452 |
| Avanir Pharmaceuticals Announces Notice Of Allowance Of U.S. Patent Application Covering NUEDEXTA. |
|
|
Jul 2, 2012 |
1347 |
| Oral care tablet. |
|
|
Jul 1, 2012 |
116 |
| Student proves his creative design mind with an innovative hanger. |
|
|
Jul 1, 2012 |
309 |
| Mylan Confirms First-to-File Patent Challenge Relating to Pristiq Tablets. |
|
|
Jun 28, 2012 |
688 |
| Global Information, Inc. Announces New Market Forecasts For Drug Discovery Industry as it Emerges from Recession. |
|
|
Jun 26, 2012 |
1321 |
| Teva Announces Favorable Court Ruling in COPAXONE[R] Patent Infringement Litigation. |
|
|
Jun 23, 2012 |
956 |
| TherapeuticsMD, Inc. Files for Two Additional Patents on Prescription Products for Treatment of Menopausal Symptoms & Related Conditions. |
|
|
Jun 21, 2012 |
499 |
| AcelRx Pharmaceuticals Receives First U.S. Patent for Small-Volume Oral Transmucosal Dosage Forms. |
|
|
Jun 20, 2012 |
974 |
| U.S. District Court Rules Against Merck in NASONEX[R] (mometasone furoate monohydrate) Patent Lawsuit. |
|
|
Jun 15, 2012 |
679 |
| Patent Expirations Put More Than $290 Billion in Prescription Drug Sales at Risk Through 2018. |
|
|
Jun 13, 2012 |
784 |
| BIO to Release Intellectual Property Rights Report at 2012 BIO International Convention. |
|
|
Jun 13, 2012 |
926 |
| Mountain View Pharmaceuticals Receives European Patent on Potential Long-Acting Drug for Multiple Sclerosis. |
|
|
Jun 11, 2012 |
770 |
| Imminent Patent Expiry of Key Blockbuster Drugs to Benefit Generics Manufacturers, Anticipates Frost & Sullivan. |
|
|
Jun 1, 2012 |
1010 |
| Imminent Patent Expiry of Key Blockbuster Drugs to Benefit Generics Manufacturers, Anticipates Frost & Sullivan. |
|
|
Jun 1, 2012 |
1020 |
| Research and Markets: Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution. |
|
|
May 31, 2012 |
393 |
| Research and Markets: Generics in Cardiovascular Diseases Market to 2018 Report - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution. |
|
Report |
May 30, 2012 |
411 |
| Horizon Pharma Announces Issuance of U.S. Patent Covering RAYOS (delayed-release prednisone). |
|
|
May 29, 2012 |
660 |
| Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand. |
|
|
May 29, 2012 |
845 |
| Watson Announces Lidoderm Patent Challenge Settlement. |
|
|
May 29, 2012 |
1072 |
| Research and Markets: Four-S Fortnightly PharmaHealth Track - Newsletter on Indian Healthcare Industry - Issue 5 - Cipla Makes Significant Price Cuts on 3 Cancer Drugs. |
|
|
May 25, 2012 |
374 |
| Auxilium Pharmaceuticals, Inc. and FCB I LLC File Lawsuit Against Watson for Infringement of Testim Patents. |
|
|
May 24, 2012 |
1789 |
| Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc. |
|
|
May 23, 2012 |
407 |
| Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients. |
|
|
May 21, 2012 |
734 |
| Watson Confirms Lo Loestrin Fe Patent Challenge. |
|
|
May 18, 2012 |
836 |
| Oramed Pharmaceuticals Granted Israeli Patent for Its Core Technology in Oral Delivery of Proteins. |
|
|
May 16, 2012 |
747 |
| Cumberland Pharmaceuticals Reports First Quarter 2012 Financial Results. |
|
|
May 3, 2012 |
1564 |
| Pharmaceuticals giant's departing boss to receive pounds 40m 'golden goodbye'. |
|
|
Apr 30, 2012 |
166 |
| Pharmaceutical boss's pounds 40m payout under fire. |
|
|
Apr 30, 2012 |
395 |
| Rexahn Pharmaceuticals Issued Japanese Patent for New Anti-cancer Compounds. |
|
|
Apr 30, 2012 |
581 |
| Merck Wins U.S. ZETIA[R] (ezetimibe)/ VYTORIN[R] (ezetimibe/simvastatin) Patent Infringement Lawsuit. |
|
|
Apr 27, 2012 |
684 |
| Regulus Receives Allowance from Japan and U.S. Patent Offices for HCV Intellectual Property, Expanding Leading Worldwide Patent Estate. |
|
|
Apr 23, 2012 |
1382 |
| Acetylon Announces Issuance of a United States Patent with Composition of Matter Claims for Its Lead HDAC6 Inhibitor Drug Candidate ACY-1215. |
|
|
Apr 20, 2012 |
618 |
| Positive Currency Effects Help Global Pharmaceutical Market Grow by 5.3 Percent in 2011, Although Lower Growth Expected Going Forward Due to Cost Containment and Key Patent Expiries. |
|
Industry overview |
Apr 19, 2012 |
599 |
| Watson Confirms Glumetza[R] Patent Challenge. |
|
|
Apr 19, 2012 |
777 |
| Opsona Therapeutics announces the issuance of new patent from the European Patent Office (EPO) covering the development and use of an antibody directed against Toll-like Receptor TLR-2. |
|
|
Apr 17, 2012 |
650 |
| CytRx Announces Issuance of Key U.S. Patent Covering INNO-206 Linker Technology. |
|
|
Apr 12, 2012 |
1000 |
| Alitair Announces Notice of Patent Allowance for its Platform Drug Delivery Technology, REA[TM]. |
|
|
Apr 12, 2012 |
322 |
| Impax Laboratories Confirms Patent Challenge Relating to Generic GRALISE[R] 300 mg and 600 mg. |
|
|
Apr 12, 2012 |
877 |
| MAP Pharmaceuticals Provides Update on LEVADEX[R] Program. |
|
|
Apr 12, 2012 |
643 |
| AcelRx Pharmaceuticals Receives Two Notices of Allowance for Small-Volume Oral Transmucosal Dosage Forms. |
|
|
Apr 11, 2012 |
1045 |
| XenoPort Awarded U.S. Patent Directed to Composition and Formulations of XP23829, a Novel Fumarate Analog for the Potential Treatment of Relapsing-Remitting Multiple Sclerosis and Psoriasis. |
|
|
Apr 4, 2012 |
763 |
| Lebanon may be blacklisted for not enforcing pharmaceutical patents. |
|
|
Apr 3, 2012 |
601 |
| Watson Confirms LUMIGAN(R) and LATISSE(R) Patent Challenges. |
|
|
Apr 3, 2012 |
829 |
| Intellectual property, pharmaceuticals and public health; access to drugs in developing countries. |
|
Book review |
Apr 1, 2012 |
220 |
| Prismic Pharmaceuticals acquires license to omega 3 patents. |
|
|
Apr 1, 2012 |
193 |
| India sets precedent for overcoming drug price barriers. |
Bateman, Chris |
|
Apr 1, 2012 |
556 |
| Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion. |
|
|
Mar 28, 2012 |
3659 |
| Research and Markets: Pakistan Pharmaceuticals and Healthcare Report Q2 2012 - In January 2012, Prime Minister Yousaf Raza Gilani Stated That Pakistan Was Committed To Eradicating Polio by End of 2012. |
|
Report |
Mar 23, 2012 |
394 |
| Watson Confirms NIASPAN(R) Patent Challenge. |
|
|
Mar 19, 2012 |
642 |
| Research and Markets: Which Strategies can Big Pharmaceutical Companies Use to Manage the Impact of Patent Protection Loss? |
|
|
Mar 17, 2012 |
429 |
| United Therapeutics Files Lawsuit Against Sandoz for Infringement of Remodulin Patents. |
|
|
Mar 15, 2012 |
645 |
| Watson Confirms BYSTOLIC(R) Patent Challenge. |
|
|
Mar 14, 2012 |
789 |
| Alnylam Retains Key Claims for Kinesin Spindle Protein (KSP) RNAi Patent in Interference Proceedings. |
|
|
Mar 14, 2012 |
1209 |
| Mountain View Pharmaceuticals Announces Receipt of a U.S. Patent on Next-Generation PEGylation Technology (PharmaPEG). |
|
|
Mar 14, 2012 |
613 |
| Forest Laboratories, Inc. Files Lawsuits against Several Companies for Infringement of BYSTOLIC[R] Patent. |
|
|
Mar 14, 2012 |
416 |
| Cortex Reports Issuance of Next Generation of AMPAKINE[R] Patents. |
|
|
Mar 13, 2012 |
974 |
| A cheap drug for cancer in India soon. |
|
|
Mar 13, 2012 |
370 |
| Pernix Therapeutics' Subsidiary Macoven Pharmaceuticals, LLC Named in Suit by Merck, Pamlab, L.L.C. and Others for Alleged Patent Violations. |
|
|
Mar 6, 2012 |
390 |
| Idenix Pharmaceuticals Announces Declaration of a Patent Interference by the USPTO. |
|
|
Mar 6, 2012 |
773 |
| Cumberland Pharmaceuticals Reports 2011 Annual Financial Results. |
|
|
Feb 29, 2012 |
9985 |
| Research and Markets: China's Guidebook for Pharmaceutical Patent Protection: An Essential Resource for Overseas and Multinational Pharmaceutical Companies. |
|
|
Feb 29, 2012 |
527 |
| MAP Pharmaceuticals Issued Additional U.S. Patent for Methods of Achieving Rapid Treatment of Migraine Based Upon Pharmacokinetic Profile. |
|
|
Feb 23, 2012 |
622 |
| US Patent Protection for Pulmaquin[TM] Is Extended with Issuance of a Composition of Matter Patent. |
|
|
Feb 21, 2012 |
831 |
| BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals. |
|
|
Feb 16, 2012 |
1355 |
| ARIAD Announces Issuance of Key U.S. Patent on Ponatinib. |
|
|
Feb 15, 2012 |
633 |
| Intellect Neurosciences Submits Statement Setting Grounds for Appeal in European Patent Proceedings. |
|
|
Feb 14, 2012 |
949 |
| Watson Confirms Beyaz(R) Patent Challenge. |
|
|
Feb 10, 2012 |
786 |
| Mylan Intends to Challenge Unfavorable Verdict in Patent Trial Related to Mylan's Generic Version of Sunovion's Xopenex[R] Inhalation Solution. |
|
|
Feb 10, 2012 |
298 |
| Watson Reaches Settlement with Mallinckrodt Over Exalgo(R). |
|
|
Jan 26, 2012 |
722 |
| Boston Scientific Announces Favorable Ruling in Patent Infringement Case. |
|
|
Jan 23, 2012 |
662 |
| Perrigo Confirms Filing for Generic Version of Astepro[R] Nasal Spray and Announcement of Patent Infringement Lawsuit by Meda Pharmaceuticals. |
|
|
Jan 23, 2012 |
694 |
| Antipsychotics Market to 2017 - Patent Expiries for Zyprexa, Abilify, Seroquel and Geodon and the Launch of Generic Versions Will Limit Commercial Opportunities for Pipeline Molecules. |
|
|
Jan 19, 2012 |
2944 |
| Ampio Pharmaceuticals' Zertane[TM] Patent Estate Bolstered by Two New European Patents. |
|
|
Jan 17, 2012 |
683 |
| Research and Markets: Impact of Patent Expiry on Global Generic Drugs Market - Trends, Opportunities and Challenges Post 2011 Focuses On the Current Generics Market Globally and the Impact of Patent Expirations. |
|
Industry overview |
Jan 17, 2012 |
406 |
| Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis Market to Decline with Patent Expiry of Celebrex in 2014. |
|
|
Jan 12, 2012 |
4463 |
| Dermatology Therapeutics Market to 2017 - Alopecia Market is Forecast to Decline Due to Patent Expiry of Finasteride in 2013 and Weak Pipeline. |
|
Industry overview |
Jan 12, 2012 |
4369 |
| Court Decides in Favor of Makhteshim Agan: Mai's New Fipronil-Based Insecticides do not Infringe BASF and Bayer Patents. |
|
|
Jan 10, 2012 |
563 |
| Mylan Confirms First-to-File Patent Challenge Relating to Actoplus Met[R] XR Tablets. |
|
|
Jan 9, 2012 |
545 |
| Tris Pharma Announces US Patent Grant Covering Platform Technology. |
|
|
Jan 6, 2012 |
361 |
| Pulmatrix Announces Grant of Patent Supporting Its Novel Pulmonary Drug Therapies. |
|
|
Jan 5, 2012 |
625 |
| European Patent Office Upholds Synergy Pharmaceuticals' Grant of Claims to Plecanatide. |
|
|
Jan 4, 2012 |
767 |
| Fitch: Macro Headwinds, Patent Cliff, & Fiscal Stresses Remain Headlines for U.S. Healthcare Sector. |
|
|
Dec 22, 2011 |
740 |
| I'm still your baby: Canada's continuing support of U.S. linkage regulations for pharmaceuticals. |
Bouchard, Ron A. |
|
Dec 22, 2011 |
31637 |
| Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimer's Disease From Merck. |
|
|
Dec 21, 2011 |
564 |
| Intellect Neurosciences Files Appeal in Europe in Response to Opposition Proceedings Instituted by Elan Pharmaceuticals and Wyeth/Pfizer. |
|
|
Dec 15, 2011 |
812 |
| Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie. |
|
|
Dec 13, 2011 |
322 |
| Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie. |
|
|
Dec 13, 2011 |
349 |
| Spectrum Pharmaceuticals Affirms Strong Patent Protection for FUSILEV[R] (levoleucovorin) Through December 31, 2019. |
|
|
Dec 9, 2011 |
1157 |
| Aradigm Selects Pulmaquin[TM] for Phase 3 Development and Announces Issuance of Its First U.S. Patent Covering Inhaled Ciprofloxacin Formulations. |
|
|
Dec 7, 2011 |
847 |
| Ampio Pharmaceuticals Awarded European Patent that Strengthens Intellectual Property Protection for its key drug Ampion(TM). |
|
|
Dec 7, 2011 |
572 |
| Shionogi & Co., Ltd. and Shionogi Inc. Announce a Favorable Decision In FORTAMET[R] Preliminary Injunction Proceedings. |
|
|
Dec 7, 2011 |
631 |
| Bayer HealthCare LLC Stops Trademark Infringement by Indian Pharmaceutical Company. |
|
|
Dec 6, 2011 |
764 |
| MEDA: Astepro patent granted. |
|
|
Dec 6, 2011 |
448 |
| United States Patent and Trademark Office Upholds Key Santaris Pharma A/S LNA Patents in Two Re-Examination Cases Brought by Isis Pharmaceuticals. |
|
|
Nov 30, 2011 |
1157 |
| Antares Pharma Announces Issuance of New U.S. Patent Covering LibiGel[R]. |
|
|
Nov 29, 2011 |
795 |
| BioSante Pharmaceuticals Announces Issuance of New LibiGel[R] Method of Use Patent. |
|
|
Nov 29, 2011 |
1042 |
| IPO Education Foundation Honors Top Inventors of 2011. |
|
|
Nov 29, 2011 |
550 |
| Femina Pharma Announces ALJ's Denial of Merck's Motion for Summary Determination on Domestic Industry in ITC Patent Dispute Concerning NuvaRing. |
|
|
Nov 28, 2011 |
599 |
| Impax Laboratories Confirms Patent Challenge Relating to Generic FENTORA[R]. |
|
|
Nov 21, 2011 |
719 |
| Research and Markets: Cefozopran Pipeline Developer - Comprehensive Patent Searching. |
|
|
Nov 17, 2011 |
335 |
| Alnylam Pharmaceuticals Grants InterfeRx[TM] Intellectual Property License to Sylentis for Development and Commercialization of RNAi Therapeutics. |
|
|
Nov 16, 2011 |
1499 |
| Ampio Pharmaceuticals Expands Patent Portfolio of Drugs for Treating Inflammatory Diseases. |
|
|
Nov 16, 2011 |
588 |
| Affymax and Janssen Biotech Settle Patent Dispute. |
|
|
Nov 9, 2011 |
810 |
| Antares Pharma Reports Third Quarter 2011 Financial and Operating Results. |
|
Financial report |
Nov 8, 2011 |
5249 |
| Research and Markets: APIs in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape. |
|
|
Nov 2, 2011 |
568 |
| Regulus Therapeutics Expands Worldwide Patent Coverage on microRNA-122 to Treat Hepatitis C Virus (HCV) Infection. |
|
|
Nov 2, 2011 |
1441 |
| Dicerna Pharmaceuticals Awarded Notice of Allowance by U.S. Patent and Trademark Office for Patent Claims Broadly Covering Dicer Substrate siRNA Molecules. |
|
|
Nov 1, 2011 |
692 |
| Intellect Neurosciences/ViroPharma Sign $126.5 Mil Deal. |
|
|
Nov 1, 2011 |
731 |
| Anatabloc. |
|
|
Nov 1, 2011 |
102 |
| Painting by numbers: adding numbers, be they Dollars or percentages, to the debate on patent expiries and the progression of generics, paints a sobering reality. |
Robinson, Kevin |
|
Nov 1, 2011 |
869 |
| World-leading Biomedical Engineer, Dr Robert Langer, Receives Economist Innovation Award for Bioscience Sponsored by Astellas Pharma Europe Ltd. |
|
|
Oct 21, 2011 |
923 |
| Robbins Umeda LLP Announces an Investigation of KV Pharmaceutical Company. |
|
|
Oct 21, 2011 |
519 |
| Mylan's Dey Pharma Successfully Obtains Patent Reexamination Certificates for Two Perforomist Patents. |
|
|
Oct 20, 2011 |
622 |
| Nutra Pharma Receives Patent for Their Multiple Sclerosis Drug. |
|
|
Oct 19, 2011 |
903 |
| Perrigo Confirms Filing for Generic Version of PATANASE Nasal Spray and Announcement of Patent Infringement Lawsuit by Alcon Laboratories. |
|
|
Oct 18, 2011 |
805 |
| Watson Confirms Atelvia(TM) Patent Challenge. |
|
|
Oct 17, 2011 |
724 |
| Noven Files Patent Infringement Lawsuit against Watson Pharmaceuticals. |
|
|
Oct 13, 2011 |
308 |
| Rexahn Pharmaceuticals Granted US Patent for Novel Anti-cancer Isoquinolinamine Compounds. |
|
|
Oct 12, 2011 |
611 |
| Research and Markets: 2011 Chinese Patent Drug Processing Industry - Investment, Import/Export, Competition, and More... |
|
Industry overview |
Oct 12, 2011 |
313 |
| Although Bisphosphonates Will Continue to Dominate Osteoporosis Treatment Through 2020, Patent Expiries of Risedronate, Reclast/Aclasta and Boniva/Bonviva Will Trigger a Decline in Sales for This Drug Class. |
|
|
Oct 11, 2011 |
621 |
| Maxygen Announces Final Rejection of All Claims of Amgen '804 Patent in Inter Partes Reexamination Proceeding. |
|
|
Oct 10, 2011 |
642 |
| Fitch: Patent Reform Manageable for Large U.S. Healthcare Innovators. |
|
|
Oct 6, 2011 |
359 |
| Antares Pharma Granted New U.S. Patent Covering VIBEX[TM] Injector Technology. |
|
|
Oct 4, 2011 |
1211 |
| Research and Markets: Ciclesonide - Eliminate Unnecessary Risk With the Industry Benchmark in Comprehensive Patent Information. |
|
|
Oct 4, 2011 |
435 |
| Ampio Pharmaceuticals Receives Notice of Allowance of its Two Patent Applications on the Combination of Zertane(TM) with Erectile Dysfunction Drugs in Canada. |
|
|
Sep 28, 2011 |
704 |
| Boston Scientific Announces Favorable Appellate Court Ruling Affirming Non-Infringement of Johnson & Johnson Patent. |
|
|
Sep 28, 2011 |
1011 |
| Watson Confirms Amphastar Patent Lawsuit. |
|
|
Sep 22, 2011 |
788 |
| Celator[R] Pharmaceuticals Granted U.S. Patent Covering Lead Cancer Product. |
|
|
Sep 21, 2011 |
721 |
| Rock Creek Pharmaceuticals Discloses Further Anatabine Patent Filing. |
|
|
Sep 20, 2011 |
1274 |
| Fitch: Banner Year for New Medicines Unlikely To Overcome Record Patent Expiration. |
|
|
Sep 16, 2011 |
326 |
| A Win for Innovation: President Signs America Invents Act. |
|
|
Sep 16, 2011 |
638 |
| Research and Markets: New Zealand Pharmaceuticals and Healthcare Report Q4 2011 - In June 2011, Pfizer Launched a Generic Version of Its Erectile Dysfunction Medication Viagra (Sildenafil) In New Zealand. |
|
Report |
Sep 16, 2011 |
366 |
| Five New Patents Issued for Mannatech's Product Technologies. |
|
|
Sep 14, 2011 |
741 |
| Research and Markets: Doxercalciferol - Eliminate Unnecessary Risk with the Industry Benchmark in Comprehensive Patent Information. |
|
|
Sep 8, 2011 |
361 |
| Anthera Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application Covering A-002 Plus Statin Compositions. |
|
|
Sep 8, 2011 |
817 |
| Research and Markets: Bepotastine - Eliminate Unnecessary Risk with the Industry Benchmark in Comprehensive Patent Information. |
|
|
Sep 7, 2011 |
363 |
| Research and Markets: Armodafinil - Eliminate Unnecessary Risk With The Industry Benchmark In Comprehensive Patent Information. |
|
|
Sep 7, 2011 |
368 |
| Rexahn Pharmaceuticals Announces US Patent Issued for CNS-based Treatment of Sexual Dysfunction. |
|
|
Sep 6, 2011 |
540 |
| Research and Markets: Lisdexamfetamine - Eliminate Unnecessary Risk with the Industry Benchmark in Comprehensive Patent Information. |
|
|
Sep 6, 2011 |
385 |
| Impax Laboratories Confirms Patent Challenge Relating to Generic NUEDEXTA[R] 20 mg/10 mg. |
|
|
Aug 31, 2011 |
702 |
| Unigene Successfully Defends its Robust Intellectual Property Portfolio. |
|
|
Aug 30, 2011 |
1130 |
